Malaria DNA vaccine (Okairos)

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NameMalaria DNA vaccine (Okairos)
Drug Alias NameAdCh63 ME-TRAP疟疾DNA疫苗 - Okairos疟疾基因疫苗 - OkairosChAd63 ME-TRAPME-TRAP malaria DNA vaccine +[7] 
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria, FalciparumMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesReithera Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Oxford
Active IndicationsN/A
Inactive IndicationsMalaria, FalciparumMalaria

Other Information

ATC CodeN/A
Related LinksN/A